Usefulness of ischemia-modified albumin in predicting oxidative stress in patients with vitiligo

Biomark Med. 2017 May;11(6):439-449. doi: 10.2217/bmm-2016-0259. Epub 2017 Jun 9.

Abstract

Aim: To investigate the emphasis of oxidative stress in the pathogenesis of vitiligo through an evaluation of ischemia-modified albumin (IMA). Results/methodology: IMA was of higher statistical significance in patients than in the control group (IMA: 0.57 ± 0.2 vs 0.52 ± 0.2 ΔABSU; p < 0.0001). IMA (p < 0.0001; OR: 8.9; 95% CI = 3.1-26.1) was found as an independent predictor of oxidative stress. Increases in affected body surface area and age were found to be independent risk factors for IMA. The sensitivity, specificity and positive and negative predictive values and capacity of IMA were higher than other studied biomarkers.

Discussion/conclusion: IMA can be detected in the condition of oxidative stress in vitiligo; it has great potential as a biomarker of said condition, when compared with other studied biomarkers.

Keywords: IMA; antioxidative system; balance; bioinformatics; contributing factors; enzyme activity; oxidative stress; usefulness; vitiligo.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxidative Stress*
  • Prognosis
  • Serum Albumin, Human
  • Vitiligo / blood
  • Vitiligo / diagnosis*
  • Vitiligo / metabolism*
  • Young Adult

Substances

  • Biomarkers
  • ischemia-modified albumin
  • Serum Albumin, Human